GSK and Alphabet team up to find biolectronic cures

Google’s parent company Alphabet is teaming up with British drug company GlaxoSmithKline to invest in bioelectronics. The aim is to treat diseases by targeting the electronic signals that pass along the body’s nerves. Chris Nuttall discusses the prospects for this new branch of medicine with the FT’s Science editor Clive Cookson Hosted on Acast. See acast.com/privacy for more information.